AAAAAA

   
Results: 1-25 | 26-50
Results: 1-25/50
DOES PREGNANCY INFLUENCE THE COURSE OF HIV-INFECTION - EVIDENCE FROM 2 LARGE SWISS COHORT STUDIES
Authors: WEISSER M RUDIN C BATTEGAY M PFLUGER D KULLY C EGGER M
Citation: M. Weisser et al., DOES PREGNANCY INFLUENCE THE COURSE OF HIV-INFECTION - EVIDENCE FROM 2 LARGE SWISS COHORT STUDIES, Journal of acquired immune deficiency syndromes and human retrovirology, 17(5), 1998, pp. 404-410
GENOTYPE DISTRIBUTION OF HEPATITIS-C VIRUS-INFECTION IN GREECE - CORRELATION WITH DIFFERENT RISK-FACTORS AND RESPONSE TO INTERFERON THERAPY
Authors: DIAMANTIS I VAFIADIS I VOSKARIDOU E DELLATETSIMA J JAGGI N GYR K BATTEGAY M
Citation: I. Diamantis et al., GENOTYPE DISTRIBUTION OF HEPATITIS-C VIRUS-INFECTION IN GREECE - CORRELATION WITH DIFFERENT RISK-FACTORS AND RESPONSE TO INTERFERON THERAPY, European journal of gastroenterology & hepatology, 10(1), 1998, pp. 75-79
RELATIONSHIP BETWEEN ERYTHEMA OF THE PROXIMAL NAILFOLD IN HIV-INFECTED PATIENTS AND HEPATITIS-C VIRUS-INFECTION
Authors: COURVOISIER S GROB H WEISSER M ITIN PH BATTEGAY M
Citation: S. Courvoisier et al., RELATIONSHIP BETWEEN ERYTHEMA OF THE PROXIMAL NAILFOLD IN HIV-INFECTED PATIENTS AND HEPATITIS-C VIRUS-INFECTION, European journal of clinical microbiology & infectious diseases, 17(8), 1998, pp. 596-597
HUMAN-IMMUNODEFICIENCY-VIRUS MUTATION AND CHANGES IN CD4 T-CELL LEVELS DURING ANTIRETROVIRAL THERAPY
Authors: BATTEGAY M
Citation: M. Battegay, HUMAN-IMMUNODEFICIENCY-VIRUS MUTATION AND CHANGES IN CD4 T-CELL LEVELS DURING ANTIRETROVIRAL THERAPY, European journal of clinical microbiology & infectious diseases, 17(5), 1998, pp. 301-303
HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY DURING EARLY HIV-INFECTION REVERSES T-CELL ACTIVATION AND MATURATION ABNORMALITIES
Authors: BISSET LR CONE RW HUBER W BATTEGAY M VERNAZZA PL WEBER R GROB PJ OPRAVIL M
Citation: Lr. Bisset et al., HIGHLY-ACTIVE ANTIRETROVIRAL THERAPY DURING EARLY HIV-INFECTION REVERSES T-CELL ACTIVATION AND MATURATION ABNORMALITIES, AIDS, 12(16), 1998, pp. 2115-2123
ANTIRETROVIRAL THERAPY AND ANTICONVULSANT DRUGS
Authors: HUG B KAESER YA HAEFELI WE BATTEGAY M
Citation: B. Hug et al., ANTIRETROVIRAL THERAPY AND ANTICONVULSANT DRUGS, Schweizerische medizinische Wochenschrift, 128(29-30), 1998, pp. 1138-1144
HEPATITIS ASSOCIATED WITH HEPATITIS-A SUPERINFECTION IN PATIENTS WITHCHRONIC HEPATITIS-C
Authors: BATTEGAY M NAEF M BUCHNER HC
Citation: M. Battegay et al., HEPATITIS ASSOCIATED WITH HEPATITIS-A SUPERINFECTION IN PATIENTS WITHCHRONIC HEPATITIS-C, The New England journal of medicine, 338(24), 1998, pp. 1771-1772
INTERFERON-ALPHA ACTIVATES SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION-5 AND TRANSCRIPTION-6 IN DAUDI CELLS
Authors: FASLERKAN E PANSKY A WIEDERKEHR M BATTEGAY M HEIM H
Citation: E. Faslerkan et al., INTERFERON-ALPHA ACTIVATES SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION-5 AND TRANSCRIPTION-6 IN DAUDI CELLS, European journal of biochemistry, 254(3), 1998, pp. 514-519
HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY
Authors: OPRAVIL M PECHERE M SPEICH R JOLLERJEMELKA HI JENNI R RUSSI EW HIRSCHEL B LUTHY R BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: M. Opravil et al., HIV-ASSOCIATED PRIMARY PULMONARY-HYPERTENSION - A CASE-CONTROL STUDY, American journal of respiratory and critical care medicine, 155(3), 1997, pp. 990-995
CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT
Authors: STALDER N SUDRE P OLMARI M OPRAVIL M GABRIEL V SANSONETTI A VONOVERBECK J HERBORT CP HIRSCHEL B BATTEGAY M BURGISSER P JEANNEROD L EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: N. Stalder et al., CYTOMEGALOVIRUS RETINITIS - DECREASED RISK OF BILATERALITY WITH INCREASED USE OF SYSTEMIC TREATMENT, Clinical infectious diseases, 24(4), 1997, pp. 620-624
IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY
Authors: EGGER M HIRSCHEL B FRANCIOLI P SUDRE P WIRZ M FLEPP M RICKENBACH M MALINVERNI R VERNAZZA P BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W GROB P GRUNINGER U JEANNEROD L LEDERGERBER B LUTHY R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RUTSCHMANN O ZANETTI G
Citation: M. Egger et al., IMPACT OF NEW ANTIRETROVIRAL COMBINATION THERAPIES IN HIV-INFECTED PATIENTS IN SWITZERLAND - PROSPECTIVE MULTICENTER STUDY, BMJ. British medical journal, 315(7117), 1997, pp. 1194-1199
EOSINOPHILIA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: TIETZ A SPONAGEL L ERB P BUCHER H BATTEGAY M ZIMMERLI W
Citation: A. Tietz et al., EOSINOPHILIA IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS, European journal of clinical microbiology & infectious diseases, 16(9), 1997, pp. 675-677
INFLUENCE OF HEPATITIS-G VIRUS-INFECTION ON LIVER-DISEASE
Authors: DIAMANTIS ID KOUROUMALIS E KOULENTAKI M FASLERKAN E SCHMID PA HIRSCH HH BUHLER H GYR K BATTEGAY M
Citation: Id. Diamantis et al., INFLUENCE OF HEPATITIS-G VIRUS-INFECTION ON LIVER-DISEASE, European journal of clinical microbiology & infectious diseases, 16(12), 1997, pp. 916-919
A SPECIFIC ANTIBODY-RESPONSE TO HCV E2 ELICITED IN MICE BY INTRAMUSCULAR INOCULATION OF PLASMID DNA CONTAINING CODING SEQUENCES FOR E2
Authors: TEDESCHI V AKATSUKA T SHIH JWK BATTEGAY M FEINSTONE SM
Citation: V. Tedeschi et al., A SPECIFIC ANTIBODY-RESPONSE TO HCV E2 ELICITED IN MICE BY INTRAMUSCULAR INOCULATION OF PLASMID DNA CONTAINING CODING SEQUENCES FOR E2, Hepatology, 25(2), 1997, pp. 459-462
DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS
Authors: LOW N PFLUGER D EGGER M BATTEGAY M BERNASCONI E BURGISSER P ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U HIRSCHEL B JEANNEROD L LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W PIFFARETTI GC RICKENBACH M RUTSCHMANN O VERNAZZA P VONOVERBECK J
Citation: N. Low et al., DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN THE SWISS HIV COHORT STUDY - INCREASING INCIDENCE, UNCHANGED PROGNOSIS, AIDS, 11(9), 1997, pp. 1165-1171
TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR
Authors: LORENZI P YERLY S ABDERRAKIM K FATHI M RUTSCHMANN OT VONOVERBECK J LEDUC D PERRIN L HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FLEPP M FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: P. Lorenzi et al., TOXICITY, EFFICACY, PLASMA DRUG CONCENTRATIONS AND PROTEASE MUTATIONSIN PATIENTS WITH ADVANCED HIV-INFECTION TREATED WITH RITONAVIR PLUS SAQUINAVIR, AIDS, 11(12), 1997, pp. 95-99
PERIUNGUAL ERYTHEMA IN HIV-INFECTED PATIENTS - REPLY
Authors: ITIN PH BATTEGAY M GASSER P
Citation: Ph. Itin et al., PERIUNGUAL ERYTHEMA IN HIV-INFECTED PATIENTS - REPLY, Journal of the American Academy of Dermatology, 37(6), 1997, pp. 1018-1019
HIGH PREVALENCE AND COINFECTION RATE OF HEPATITIS-G AND HEPATITIS-C INFECTIONS IN INTRAVENOUS DRUG-ADDICTS
Authors: DIAMANTIS I BASSETTI S ERB P LADEWIG D GYR K BATTEGAY M
Citation: I. Diamantis et al., HIGH PREVALENCE AND COINFECTION RATE OF HEPATITIS-G AND HEPATITIS-C INFECTIONS IN INTRAVENOUS DRUG-ADDICTS, Journal of hepatology, 26(4), 1997, pp. 794-797
ORAL MANIFESTATION OF DISSEMINATED MYCOBACTERIUM-KANSASII INFECTION IN A PATIENT WITH AIDS
Authors: NUESCH R BATTEGAY M ZIMMERLI W THUMSHIRN M GILLI L ITIN PH
Citation: R. Nuesch et al., ORAL MANIFESTATION OF DISSEMINATED MYCOBACTERIUM-KANSASII INFECTION IN A PATIENT WITH AIDS, Dermatology, 192(2), 1996, pp. 183-184
RISK-FACTORS FOR TUBERCULOSIS AMONG HIV-INFECTED PATIENTS IN SWITZERLAND
Authors: SUDRE P HIRSCHEL B TOSCANI L LEDERGERBER B RIEDER HL BATTEGAY M ERB P MALINVERNI R MATTER L PICHLER WJ PERRIN L FREI P VONOVERBECK J FIERZ W VERNAZZA P LUTHY R GROB PJ FRANCIOLI P KNOPFLI D MEISTER T
Citation: P. Sudre et al., RISK-FACTORS FOR TUBERCULOSIS AMONG HIV-INFECTED PATIENTS IN SWITZERLAND, The European respiratory journal, 9(2), 1996, pp. 279-283
HEPATITIS-G VIRUS IN HCV INFECTED IV DRUG-ADDICTS - HIGH PREVALENCE BUT NO INFLUENCE ON HEPATITIS OUTCOME
Authors: DIAMANTIS I BASSETTI S ERB P LADEWIG D GYR K BATTEGAY M
Citation: I. Diamantis et al., HEPATITIS-G VIRUS IN HCV INFECTED IV DRUG-ADDICTS - HIGH PREVALENCE BUT NO INFLUENCE ON HEPATITIS OUTCOME, Hepatology, 24(4), 1996, pp. 405-405
HEPATITIS-G VIRUS IN CHRONIC LIVER-DISEASES AND BLOOD-DONORS WITH HCVAND HBSAG POSITIVITY
Authors: DIAMANTIS I FASLERKAN E KOUROUMALIS E KOULENTAKI M BUHLER H GYR K BATTEGAY M
Citation: I. Diamantis et al., HEPATITIS-G VIRUS IN CHRONIC LIVER-DISEASES AND BLOOD-DONORS WITH HCVAND HBSAG POSITIVITY, Hepatology, 24(4), 1996, pp. 1504-1504
IMMUNITY TO HEPATITIS-C VIRUS - A FURTHER PIECE OF THE PUZZLE
Authors: BATTEGAY M
Citation: M. Battegay, IMMUNITY TO HEPATITIS-C VIRUS - A FURTHER PIECE OF THE PUZZLE, Hepatology, 24(4), 1996, pp. 961-963
REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS
Authors: VANDELDEN C GABRIEL V SUDRE P FLEPP M VONOVERBECK J HIRSCHEL B BATTEGAY M BURGISSER P DOORLY R EGGER M ERB P FIERZ W FRANCIOLI P GROB P GRUNINGER U LEDERGERBER B LUTHY R MALINVERNI R MATTER L OPRAVIL M PACCAUD F PERRIN L PICHLER W RICKENBACH M RUTSCHMANN O VERNAZZA P
Citation: C. Vandelden et al., REASONS FOR FAILURE OF PREVENTION OF TOXOPLASMA-ENCEPHALITIS, AIDS, 10(5), 1996, pp. 509-513
ERYTHEMA OF THE PROXIMAL NAILFOLD IN HIV-INFECTED PATIENTS
Authors: ITIN PH GILLI L NUESCH R COURVOISIER S BATTEGAY M RUFLI T GASSER P
Citation: Ph. Itin et al., ERYTHEMA OF THE PROXIMAL NAILFOLD IN HIV-INFECTED PATIENTS, Journal of the American Academy of Dermatology, 35(4), 1996, pp. 631-633
Risultati: 1-25 | 26-50